For example, Pang et al. suggested that LRRC75A-AS1 suppressed multiple myeloma by targeting miR-199b-5p/PDCD4 axis (Pang et al., 2020); Chen et al. demonstrated that LRRC75A-AS1 repressed cell proliferation and migration of colorectal carcinoma (Chen et al., 2019); Li et al. confirmed that LRRC75A-AS1 facilitated cell proliferation and invasion of triple negative breast cancer by acting as a ceRNA to regulate BAALC (Li et al., 2020). Here, LRRC75A is linked to plasma cell myeloma.